POsition of Leads in Advanced heaRt Failure: the POLAR Study
NCT01515761 is an interventional trial sponsored by Sergio Thal, M.D.. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Cardiac Resynchronization Therapy and Heart Failure. The registry lists an enrollment of 60 participants at 2 sites in 1 country. The registry lists a start date of 30 Sept 2010 and a primary completion date of 31 Mar 2013.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01515761 |
| Status | Unknown |
| Study type | Interventional trial |
| Lead sponsor | Sergio Thal, M.D. |
| Enrollment | 60 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Cardiac Resynchronization Therapy and Heart Failure |
| Start | 30 Sept 2010 |
| Primary completion | 31 Mar 2013 |
| Last update posted | 24 Jan 2012 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Sergio Thal, M.D.
Southern Arizona VA Health Care System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern Arizona Va Health Care System
Tucson
Elizabeth Juneman, M.D.Hoang Thai, M.D.Sergio Thal, M.D.Recruiting
- Lexington Va Medical Center
Lexington
Samy Elayi, M.D.Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01515761
Each answer restates registry values shown on this page.
What is NCT01515761?
NCT01515761 is an interventional trial sponsored by Sergio Thal, M.D.. It studies Cardiac Resynchronization Therapy and Heart Failure.
Who leads NCT01515761?
The registry names Sergio Thal, M.D. (principal investigator, Southern Arizona VA Health Care System) as the overall official.
Where does NCT01515761 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When is NCT01515761 expected to complete?
The registry lists a primary completion date of 31 Mar 2013. The sponsor last updated the record on 24 Jan 2012.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.